Cargando…

Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis

Rabies is a fatal encephalitis caused by rabies virus (RABV), and no antiviral drugs for RABV are currently available. We report for the first time the efficacy of favipiravir (T-705) against RABV in vitro and in vivo. T-705 produced a significant, 3–4 log(10) reduction in the multiplication of stre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Kentaro, Noguchi, Kazuko, Komeno, Takashi, Furuta, Yousuke, Nishizono, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799667/ https://www.ncbi.nlm.nih.gov/pubmed/26655300 http://dx.doi.org/10.1093/infdis/jiv586

Ejemplares similares

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
por: FURUTA, Yousuke, et al.
Publicado: (2017)

Favipiravir (T-705) protects against Nipah virus infection in the hamster model
por: Dawes, Brian E., et al.
Publicado: (2018)

Rabies postexposure prophylaxis survey--Kentucky, 1994.
por: Auslander, M, et al.
Publicado: (1997)

Rabies Postexposure Prophylaxis, Marseille, France, 1994–2005
por: Gautret, Philippe, et al.
Publicado: (2008)

Rabies Postexposure Prophylaxis, New York, 1995–2000
por: Blanton, Jesse D., et al.
Publicado: (2005)

Effect of Media Warnings on Rabies Postexposure Prophylaxis, France
por: Gautret, Philippe, et al.
Publicado: (2011)

Risk of Rabies and Implications for Postexposure Prophylaxis Administration in the US
por: Charniga, Kelly, et al.
Publicado: (2023)

Inclusion of Rabishield in the WHO guidelines for rabies postexposure prophylaxis
por: Kaza, Vamsi Krishna, et al.
Publicado: (2023)

Two fatal cases of rabies in humans who did not receive rabies postexposure prophylaxis in Nigeria
por: Audu, Solomom W., et al.
Publicado: (2019)

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
por: Furuta, Yousuke, et al.
Publicado: (2009)

Bat Rabies and Human Postexposure Prophylaxis, New York, USA
por: Eidson, Millicent, et al.
Publicado: (2011)

Terrestrial Rabies and Human Postexposure Prophylaxis, New York, USA
por: Eidson, Millicent, et al.
Publicado: (2010)

Rabies encephalitis in a preschool child following postexposure prophylaxis
por: Chaitra, K. M., et al.
Publicado: (2021)

Inappropriate Administration of Rabies Postexposure Prophylaxis, Cook County, Illinois, USA
por: Steinberg, Hannah D., et al.
Publicado: (2020)

Correction: Rabies encephalitis in a preschool child following postexposure prophylaxis
Publicado: (2021)

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
por: Mendenhall, Michelle, et al.
Publicado: (2011)

1111 The Evaluation of the Results of Postexposure Rabies Prophylaxis in a Turkish State Hospital
por: Ozkaya, Deniz, et al.
Publicado: (2014)

Rabies postexposure prophylaxis in the United States: Opportunities to improve access, coordination, and delivery
por: Howington, Gavin T., et al.
Publicado: (2021)

Human rabies postexposure prophylaxis during a raccoon rabies epizootic in New York, 1993 and 1994.
por: Wyatt, J D, et al.
Publicado: (1999)

Contingency Management Facilitates the Use of Postexposure Prophylaxis Among Stimulant-Using Men Who Have Sex With Men
por: Landovitz, Raphael J., et al.
Publicado: (2014)

Lymphocyte Subsets in HIV-Exposed Uninfected Infants: The Impact of Neonatal Postexposure Prophylaxis With Zidovudine
por: Greiter, Beat M, et al.
Publicado: (2020)

Rabies Postexposure Prophylaxis for Travelers Injured by Nonhuman Primates, Marseille, France, 2001–2014
por: Blaise, Agathe, et al.
Publicado: (2015)

Simplification of Rabies Postexposure Prophylaxis: A New 2-Visit Intradermal Vaccine Regimen
por: Warrell, Mary J.
Publicado: (2019)

Evaluating Surveillance for and Estimating Administration of Rabies Postexposure Prophylaxis in the United States, 2012–2018
por: Whitehouse, Erin R., et al.
Publicado: (2021)

Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
por: Tani, Hideki, et al.
Publicado: (2016)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
por: Gowen, Brian B., et al.
Publicado: (2013)

Failure of Postexposure Prophylaxis in a Patient Given Rabies Vaccine Intramuscularly in the Gluteus Muscle, Himachal Pradesh, India
por: Bharti, Omesh Kumar, et al.
Publicado: (2018)

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP)
por: Inciarte, Alexy, et al.
Publicado: (2023)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)
por: Song, Rui, et al.
Publicado: (2019)

Preexposure and Postexposure Prophylaxis of Rabies With Adeno-Associated Virus Expressing Virus-Neutralizing Antibody in Rodent Models
por: Huang, Fei, et al.
Publicado: (2021)

Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
por: Srinivasan, Kritika, et al.
Publicado: (2021)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

Adherence to guideline recommendations for human rabies immune globulin patient selection, dosing, timing, and anatomical site of administration in rabies postexposure prophylaxis
por: Hwang, Grace S., et al.
Publicado: (2019)

Postexposure Treatment and Animal Rabies, Ontario, 1958-2000
por: Nunan, Christopher P., et al.
Publicado: (2002)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Evaluation of Antiviral Efficacy of Ribavirin, Arbidol, and T-705 (Favipiravir) in a Mouse Model for Crimean-Congo Hemorrhagic Fever
por: Oestereich, Lisa, et al.
Publicado: (2014)

Therapeutic effects of favipiravir against severe fever with thrombocytopenia syndrome virus infection in a lethal mouse model: Dose-efficacy studies upon oral administration
por: Tani, Hideki, et al.
Publicado: (2018)

HIV postexposure prophylaxis in the 21st century.
por: Henderson, D K
Publicado: (2001)

HIV postexposure prophylaxis during COVID-19
por: Junejo, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5nsnt7bleqvq4ki0j30d6857u9